ISOTHESIA NXT INHALATION ANAESTHETIC

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
ISOFLURANE
Available from:
PIRAMAL ENTERPRISES LIMITED
INN (International Name):
isoflurane(100%)
Pharmaceutical form:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Composition:
ISOFLURANE ANAESTHETIC Active 100.0 %
Units in package:
100mL; 250mL
Class:
VM - Veterinary Medicine
Manufactured by:
PIRAMAL ENTERPRISES
Therapeutic group:
BIRDS - ORNAMENTAL | CAT | DOG | HORSE | REPTILE | SMALL MAMMALS | AMAZON PARROT | BITCH | CAGED BIRD | CANARY | CASTRATE | CAT
Therapeutic area:
ANAESTHETICS/ANALGESICS
Therapeutic indications:
INHALATION ANAESTHETIC
Product summary:
Poison schedule: 4; Withholding period: WHP: Meat: Not to be used in horses i ntended for human consumption.; Host/pest details: BIRDS - ORNAMENTAL: [INHALATION ANAESTHETIC]; CAT: [INHALATION ANAESTHETIC]; DOG: [INHALATION ANAESTHETIC]; HORSE: [INHALATION ANAESTHETIC]; REPTILE: [INHALATION ANAESTHETIC]; SMALL MAMMALS: [INHALATION ANAESTHETIC]; Inhalation anaesthetic for use in horses, cats, dogs, ornamental birds, reptiles and small mammals.Do not use in animals with a known sensitivity to isoflurane or with a known susceptibility to malignant hypothermia.
Authorization status:
Registered
Authorization number:
53120
Authorization date:
2020-07-01

TEXT

LABEL: CEVA lsoflurane Inhalation Anaesthetic

FOLD

LABEL: Main panel: 1

OOmL

&

250mL

Text appearing above the Header and below the Footer lines

· not included

the label

PRESCRIPTION ANIMAL REMEDY

KEEP OUT:OF REACH OF CHILDREN

READ SAFETY DIRECTIONS BEFORE OPENING OR

U~ING

FOR ANIMAL TREATMENT ONLY

OPEN

HERE

(in top right

hand

comer

c

zip seal label'

CEVA

.Approved

ISOFLURANE

INHALAT~ON

ANAESTHETIC

Active constituent: lsoflurane 100%

For use

horses, cats, dogs,·

ornamental birds, reptiles and small

mammals.

1

OOml

[250ml]

Distributed by:

CEVA

ANIMAL HEALTH; PTY LTD

Moores

Glenorie

2157

AUSTRALIA

Phone: (02) 9652 7000

August 2011

.

.

53120_54063_Labei_RLP

_Final

Infopest

Verified

TEXT

LABEL:

CEVA

Jsoflurane

Inhalation

Anaesthetic

·.

r

FOLD

OUT

LABEL-

Main

panel:

100mL

&

250ml

Text

appearing

above

the

Header

and

below

the

Footer

lines

is

not

Included

In

the

label

Left hand

side

panel

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT

MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED in horses

intended for human consumption.

SAFETY DIRECTIONS:

May irritate the eyes and skin.

Avoid contact with eyes and skin.

Ensure

adequate ventilation during use.

FIRST AID:

If poisoning occurs, contact a doctor or Poisons Information Centre.

Phone

Australia 131126; New Zealand 0800 764 766.

Dispose

of empty container by wrapping with paper and putting in garbage.

Alternatively glass bottles should be completely emptied before disposal and

placed

a glass recycling bin.

Store

below 25°C (air conditioning). Store in tightly

dosed

original container.

Protect from direct sunlight and direct heat

Code: AP/DRUGS/220/96

Batch No:

Expiry Date:

Manufactured by: Piramal Healthcare Limited

India

APVMAApproval No: 53120/54063

11

August

2011

53120_54063_Labei_RLP

_Final

TEXT

LABEL:

CEVA

lsoflurane

Inhalation

Anaesthetic

BASE LABEL: 1

OOmL

&

250mL

Text

appearing

above

Header

be(ow

Footer

lines

included

label

Page 1 Right hand side

panel

PRESCRIPTION ANIMAL REMEDY

KEEP OUT,OF REACH OF CHILDREN

READ SAFETY

DIRE~TIONS

BEFORE OPENING OR USING

FOR ANIMAL TREATMENT ONLY

CEVA

ISOFLURANE

INHALATION ANAESTHETIC

Active, c,onstituent:

lsoflurane

100%

For use

horses, cats, dogs, ornamental birds, reptiles and small

mammals.

Distributed by:

CEVA ANIMAL HEALTH

Moores Rd Glenorie

NS)JV

2157 AUSTRALIA

Phone: (02) 9652 7000.

August2011

53120_54063_Labei_RLP

_Final

100mL [250mL]

TEXT

LABEL:

CEVA

lsoflurane

Inhalation

Anaesthetic

BASE LABEL:

100ml

&

250ml

Text

appearing

above

the

Header

and

below

the

Footer

lines

Is

not

lncludeCI

ln

tfle

label

Page 1 Left hand side

panel

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT

MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED

in

horses

intended for human consumption.

SAFETY DIRECTIONS:

May irritate the eyes and skin.

Avoid contact with eyes and skin.

Ensure

adequate ventilation during use.

FIRST AID:

poisoning occurs, contact a doctor or Poisons Information Centre.

Phone

Australia 131126; New Zealand 0800 764 766.

Dispose of empty container by wrapping with paper and putting

garbage.

Alternatively glass bottles should be completely emptied before disposal and

placed in a glass recycling bin.

Store below 25°C (air conditioning). Store

tightly closed original container.

Protect from direct sunlight and direct heat

Batch No:

Expiry Date:

Manufactured by Piramal Healthcare Limited

India

APVMA Approval No: 53120/54063

11

August

2011

53120_54063_Labei_RLP _Final

TEXT

LABEL:

CEVA

lsoflurane Inhalation Anaesthetic

FOLD

LABEL

Fold

pages;

100ml

250mL

Text

appearing

above

Header

below

Footer

lines

not included

label

Pages 2

PRESCRIPTION ANIMAL REMEDY

KEEP OUJ,OF REACH OF CHILDREN

READ SAFETY DIRECTIONS BEFORE OPENING OR USING

FOR ANI.MAL TREATMENT ONLY

CEVA

ISOFLURANE

INHALATION ANAESTHETIC

Active,,yonstituent: lsoflurane 100%

A potent non-irritant,

inhal<~nt

anaesthetic which can be used for all types

veterinary surgery in horses,,cats, dogs, ornamental birds, reptiles and small

mammals.

Description

&

Composition: A clear, colourless volatile liquid for the

generation

gaseous anaesthetic with a mildly pungent odour, containing

100% isoflurane. Chemically

is 1-chloro-2,

2-trifluroethyl-difluromethyl

ether.

DIRECTIONS FOR

<'

ISOFLURANE should. only.be used in an isoflurane specific vaporiser.

CEVA lsoflurane Inhalation Anaesthetic should be administered

using

an accurately calibrated vaporiser in

appropriate anaesthetic circuit.

Levels

anaesthesia may be altered rapidly and easily. lsoflurane may

be administered

oxygeh

oxygen/nitrous oxide mixtures.

This

product

contraindicated

use in animals

with

a known

sensitivity

isoflurane

with

a known sensitivity

malignant

hypothermia.

Precautions:

August

2011

,

53120_54063_Labei_RLP

_Final

TEXT

LABEL:

CEVA

lsoflurane

Inhalation

Anaesthetic

FOLD

OUT

LABEL

Fold

out

pages;

100mL

'and

250mL

Text

appearing

above

the

Header

and

below

the

Footer

lines

Is

not

included'

in

the

label

When using isoflurane to anaesthetise an animal with a head injury,

consideration should be given as to whether artifici,al ventilation is appropriate

maintain normal C0

levels, so that cerebral blo9d flow does not increase.

man, the action of muscle relaxants, especially those of the non-

depolarising type such as atracurium, pancuronium or vecuronium is

enhanced by isoflurane.

Similar potentiation might

b:e·

expected to occur

the target species, although there

little direct

evide:nc'e'

to this effect.

The concurrent use

sedative or analgesic drugs

(~·likely

to reduce the level

of isoflurane required to induce and maintain

anae.~ihesia.

For example,

.

opiates, alpha-2-agonists, acepromazine and benzqdiazepines have been

reported to reduce the MAC values.

Particular caution should be exercised

administering a midazolam-ketamine combination t9 an animal already

anaesthetised with isoflurane.

Pages 4

lsoflurane has been reported to interact with dry carbon dioxide absorbents to

form carbon monoxide.

order to minimise the risk

formation of carbon

monoxide in rebreathing circuits and the possibility of elevated

.,,.

carboxyhaemoglobin levels, carbon dioxide absorbents should not be allowed

to dry out..

CEVA lsoflurane Inhalation Anaesthetic has been: safely used for anaesthesia

during Caesarean section

the dog and cat.

Rep~oduction

studies have

been performed in mice, rats and rabbits with

evidence of foetal

malformation attributable to isoflurane at clinically relevant concentrations.

However, fully comprehensive data concerning its use in pregnant, breeding

or lactating animals of all target species have not been obtained.

,·l

Side Effects:

CEVA lsoflurane Inhalation Anaesthetic causes dose-related respiratory and

cardiovascular depression.

It is important that respiration and pulse should be

monitored for both rate and character.

Respiratory arrest should be treated

by assisted ventilation with air or, preferably, with oxygen supplementation.

is important that a patent airway be maintained and adequate tissue

oxygenation achieved throughout the period

anaesthesia.

Should cardiac

arrest occur, full cardiopulmonary resuscitation methods should be applied.

Cardiac arrhythmias have been reported very occasionally.

However,

lsoflurane has a weaker sensitising action on the myocardium,

the effects

of dysrhythmogenic circulating catecholamines, than halothane.

Dosage and Administration

Premedication:

CEVA lsoflurane Inhalation Anaesthetic may be used with

other drugs commonly used

veterinary anaesthetic regimes.

Drugs used

11

August

2011

53120_54063_Labei_RLP

_Final

TEXT

LABEL:

CEVA

lsoflurane

Inhalation

Anaesthetic

FOLD

OUT

LABEL

Fold

out

pages;

1

OOml

and

250ml

Text

appearing

above

the

Header

and

below

the

Footer

lines

is

not

included

in

the

label

for premedication should be selected for the individual patient.

See Contra-

indications, warnings etc for potential drug interactions.

Induction, Maintenance and Recovery:

The MAC (minimal alveolar concentration)

oxygen given below for the

target species should be used as a guide only.

The actual concentrations

required in practice will depend on many variables including concomitant use

other drugs and the clinical status of the patient.

Species

MAC(%)

Induction

(%)*

Maintenance

Horse

1.31

3.0-

5.0 (foals)

1.5-2.5

1.28

to 5.0

1.5-2.5

:

1.63

to 4.0

1.5-3.0

Ornamental birds

ca.:1.45

3.0-5.0

0.6-5.0

Reptiles

Not published

2.0-4.0

1.0-3.0

\,,!

Small Mammals

2.05.

(r~bbit)

1.34 (mouse)

2.0-3.0

0.25-2.0

1.38-2.40 (rat)

Pages 6

and7

Induction

usually

occurs

faqemask

all species, recovery

normally smooth and rapid.

Further Information

Metabolism

isoflurane is,lllinimal (about 0.2%) mainly to inorganic fluoride

and almost all of the administered isoflurane is excreted unchanged by the

lungs.

CEVA lsoflurane Inhalation Anaesthetic produces unconsciousness by its

action

the central nervous system and

a good muscle relaxant for

surgical procedures.

It has [legligible analgesic properties and consideration

should be given to the analgesic requirements of the patient before recovery

from anaesthesia takes place.

11

August

2011

53120_54063_Label_RLP

_Final

·"

TEXT

LABEL:

CEVA

lsoflurane

Inhalation

Anaesthetic

FOLD

OUT

lABEL

Fold

out

pages;

100mL

and

250mL

~·,

.

Text

appearing

above

the

Header

and

below

the

Footer

lines

is

not

included

in

'the

label

MEAT WITHHOLDING PERIOD (HORSES):

NOT TO BE USED

in

horses

intended for human consumption.

SAFETY DIRECTIONS:

May irritate the eyes and skin.

Avoid contact with eyes and skin.

Ensure

adequate ventilation during use.

·

Additional user safety information

not breathe the vapour.

The recommended oc6upational exposure (OSE)

8-hour time weighted basis is 50 ppm (UK standards).

Operating rooms should be provided with adequate ventilation and active

extraction to prevent accumulation of isoflurane vapours.

Induction and

recovery areas should be well ventilated.

Care should be taken when dispensing CEVA lsoflurane Inhalation

Anaesthetic into the vaporiser. Eyes should be protected from splashes and

plastic (not rubber) gloves should be worn.

Spillage should be contained or

removed immediately, using sawdust, sand

inert absorbents, to a well-

ventilated place.

Repeated exposure to halogenated anaesthetics has been linked to increased

miscarriages in personnel of operating theatres.

the event

a severe accidental exposure remove the operator from the

source of exposure, seek urgent medical assistance and show the label.

Wash any splashes from skin immediately with soap and water.

Contaminated eyes should

washed with water for 10 minutes.

FIRST AID:

poisoning occurs, contact a doctor or Poisons Information Centre.

Phone

Australia 131126; New Zealand 0800 764 766.

Manufactured by:

Pi

ramal Healthcare Limited

India

Pages 8

Distributed by:

CEVA ANIMAL HEALTH PTY LTD

Moores

Glenorie NSW 2157

11

August

2011

53120_54063_Labei_RLP

_Final

TEXT

LABEL:

CEVA

lsoflurane Inhalation Anaesthetic

FOLD

LABEL

Fold

pages;

10DmL

250ml

Text

appearing

above

Header

below

Footer

lines

Included

label

AUSTRALIA

Phone: (02) 9652 7000.

Dispose

of empty container by wrapping with paper and putting

garbage.

Alternatively glass bottles should

completely emptied before disposal and

placed in a glass recycling bin.

Store

below 25°C (air conditioning).

Store in tightly closed original container.

Protect from direct sunlight and direct heat.

Presentation: CEVA lsoflurane is supplied

amber colour bottles of 100 or

August

2011

53120_54063_Labei_RLP _Final

Product Name: Delvet Isoflurane Inhalation Anaesthetic

Page: 1 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATA SHEET

Issued by: Delvet Pty Ltd

Phone: +61 2 9624 8844

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 1 - Identification of Chemical Product and Company

Delvet Pty Ltd

Phone: +61 2 9624 8844

26 Powers Rd

Fax: +61 2 9624 1544

Seven Hill, NSW 2147

Substance:

Fluorinated and chlorinated aliphatic ether.

Trade Name:

Delvet Isoflurane Inhalation Anaesthetic

Other Names:

2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane

APVMA Code:

53120

Product Use:

For anaesthetising horses, cats, dogs and other small animals as listed on the

product label.

Creation Date:

October, 2008

This revision issued:

October, 2008

Section 2 - Hazards Identification

Statement of Hazardous Nature

This product is classified as:

Not classified as hazardous according to the criteria of ASCC.

Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. However, this is a C1

Combustible Liquid and for storage meets the definition of Dangerous Goods.

Risk Phrases:

Not Hazardous - No criteria found.

Safety Phrases:

S23, S24/25. Do not breathe vapours. Avoid contact with skin and eyes.

SUSDP Classification:

ADG Classification:

Class 9 (Air transport only)

UN Number:

3334, Aviation Regulated Liquid, N.O.S. (Air transport only)

Emergency Overview

Physical Description & Colour

: Clear, colourless liquid.

Odour:

Mild, ethereal odour.

Major Health Hazards:

no significant risk factors have been found for this product. This is a physiologically active

product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can

sometimes give unexpected and undesired results.

Potential Health Effects

Inhalation:

Short Term Exposure:

This product causes anaesthetic effects. Inhalation at a concentration in air of 0.5-3.0%

can induce general anaesthesia in 7 to 10 minutes, with analgesia, muscle relaxation and loss of consciousness.

Symptoms include rapid respiration, diminished mental alertness, impaired muscle coordination, faulty judgement,

depression of all sensations, emotional instability and fatigue. Isoflurane may also cause a slight decrease in

intellectual function and mood changes. In susceptible individuals, it may trigger malignant hyperthermia.

Long Term Exposure:

No data for health effects associated with long term inhalation.

Skin Contact:

Short Term Exposure:

Available data indicates that this product is not harmful. It should present no hazards in

normal use. However product may be irritating, but is unlikely to cause anything more than mild transient discomfort.

Long Term Exposure:

No data for health effects associated with long term skin exposure.

Eye Contact:

Short Term Exposure

: This product may be irritating to eyes, but is unlikely to cause anything more than mild

transient discomfort.

Long Term Exposure

: No data for health effects associated with long term eye exposure.

Product Name: Delvet Isoflurane Inhalation Anaesthetic

Page: 2 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATA SHEET

Issued by: Delvet Pty Ltd

Phone: +61 2 9624 8844

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Ingestion:

Short Term Exposure

: Significant oral exposure is considered to be unlikely. However, this product may be

irritating to mucous membranes but is unlikely to cause anything more than transient discomfort.

Long Term Exposure

: No data for health effects associated with long term ingestion.

Carcinogen Status:

ASCC:

No significant ingredient is classified as carcinogenic by ASCC.

NTP:

No significant ingredient is classified as carcinogenic by NTP.

IARC:

No significant ingredient is classified as carcinogenic by IARC.

Section 3 - Composition/Information on Ingredients

Ingredients

CAS No

Conc,%

TWA (mg/m

3

)

STEL (mg/m

3

)

Isoflurane

26675-46-7

>99

not set

not set

This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non

hazardous ingredients are also possible.

The ASCC TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day

for a 5 day working week. The STEL (Short Term Exposure Limit) is an exposure value that may be equalled (but should not be exceeded) for no

longer than 15 minutes and should not be repeated more than 4 times per day. There should be at least 60 minutes between successive exposures

at the STEL. The term "peak "is used when the TWA limit, because of the rapid action of the substance, should never be exceeded, even briefly.

Section 4 - First Aid Measures

General Information:

You should call The Poisons Information Centre if you feel that you may have been poisoned, burned or irritated by

this product. The number is 13 1126 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all

times. Have this MSDS with you when you call.

Inhalation:

First aid is not generally required. If in doubt, contact a Poisons Information Centre or a doctor.

Skin Contact:

Gently blot away excess liquid. Wash gently and thoroughly with water (use non-abrasive soap if

necessary) for 5 minutes or until chemical is removed.

Eye Contact:

Quickly and gently blot material from eyes. No effects expected. If irritation does occur, flush

contaminated eye(s) with lukewarm, gently flowing water for 5 minutes or until the product is removed. Obtain medical

advice if irritation becomes painful or lasts more than a few minutes. Take special care if exposed person is wearing

contact lenses.

Ingestion:

If product is swallowed or gets in mouth, do NOT induce vomiting; wash mouth with water and give some

water to drink. If symptoms develop, or if in doubt contact a Poisons Information Centre or a doctor.

Section 5 - Fire Fighting Measures

Fire and Explosion Hazards

: This product is classified as a C1 combustible product. There is no risk of an

explosion from this product under normal circumstances if it is involved in a fire. Vapours from this product are heavier

than air and may accumulate in sumps, pits and other low-lying spaces, forming potentially explosive mixtures. They

may also flash back considerable distances.

Fire decomposition products from this product are likely to be toxic and corrosive if inhaled. Take appropriate

protective measures.

Extinguishing Media

: Suitable extinguishing media are carbon dioxide, dry chemical, foam, water fog.

Fire Fighting

: If a significant quantity of this product is involved in a fire, call the fire brigade.

Flash point

:

>93°C

Upper Flammability Limit:

No data.

Lower Flammability Limit:

No data.

Autoignition temperature:

No data.

Flammability Class:

Section 6 - Accidental Release Measures

Accidental release

: This product is sold in small packages, and the accidental release from one of these is not

usually a cause for concern. For minor spills, clean up, rinsing to sewer and put empty container in garbage. Although

no special protective clothing is normally necessary because of occasional minor contact with this product, it is good

Product Name: Delvet Isoflurane Inhalation Anaesthetic

Page: 3 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATA SHEET

Issued by: Delvet Pty Ltd

Phone: +61 2 9624 8844

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

practice to wear impermeable gloves when handling chemical products. In the event of a major spill, prevent spillage

from entering drains or water courses and call emergency services.

Section 7 - Handling and Storage

Handling

: Keep exposure to this product to a minimum, and minimise the quantities kept in work areas. Check

Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed.

The measures detailed below under "Storage" should be followed during handling in order to minimise risks to

persons using the product in the workplace. Also, avoid contact or contamination of product with incompatible

materials listed in Section 10.

Storage

: Note that this product is combustible and therefore, for Storage, meets the definition of Dangerous Goods

in some states. If you store large quantities (tonnes) of such products, we suggest that you consult your state's

Dangerous Goods authority in order to clarify your obligations regarding their storage.

Store packages of this product in a cool place, below 25°C. Make sure that containers of this product are kept tightly

closed. Keep containers of this product in a well ventilated area. Keep away from heat and flame. Protect this product

from light. Make sure that the product does not come into contact with substances listed under "Incompatibilities" in

Section 10. Check packaging - there may be further storage instructions on the label.

Section 8 - Exposure Controls and Personal Protection

The following Australian Standards will provide general advice regarding safety clothing and equipment:

Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Industrial Clothing: AS2919, Industrial Eye

Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210.

ASCC Exposure Limits

TWA (mg/m

3

)

STEL (mg/m

3

)

Exposure limits have not been established by ASCC for this product.

No special equipment is usually needed when occasionally handling small quantities. The following instructions are

for bulk handling or where regular exposure in an occupational setting occurs without proper containment systems.

Ventilation:

This product should only be used where there is ventilation that is adequate to keep exposure below

the TWA levels. If necessary, use a fan or exhaust atmosphere to the outside.

Eye Protection:

Eye protection such as protective glasses or goggles is recommended when this product is being

used.

Skin Protection:

You should avoid contact even with mild skin irritants. Therefore you should wear suitable

impervious elbow-length gloves and facial protection when handling this product. See below for suitable material

types.

Protective Material Types:

We suggest that protective clothing be made from the following materials: rubber,

latex.

Respirator:

Usually, no respirator is necessary when using this product. However, if you have any doubts consult

the Australian Standard mentioned above.

Section 9 - Physical and Chemical Properties:

Physical Description & colour

Clear, colourless liquid.

Odour:

Mild, ethereal odour.

Boiling Point:

48-49°C at 100kPa

Freezing/Melting Point:

No specific data. Liquid at normal temperatures.

Volatiles:

Completely volatile at 100°C.

Vapour Pressure:

31.41 kPa at 20°C

Vapour Density:

No data.

Specific Gravity:

1.496 at 25°C

Water Solubility:

Insoluble.

pH:

Not applicable.

Volatility:

No data.

Odour Threshold:

No data.

Evaporation Rate:

No data.

Coeff Oil/water Distribution

No data

Autoignition temp:

No data.

Product Name: Delvet Isoflurane Inhalation Anaesthetic

Page: 4 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATA SHEET

Issued by: Delvet Pty Ltd

Phone: +61 2 9624 8844

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 10 - Stability and Reactivity

Reactivity:

This product is unlikely to react or decompose under normal storage conditions. However, if you have

any doubts, contact the supplier for advice on shelf life properties.

Conditions to Avoid:

This product should be kept in a cool place, preferably below 30°C. Keep containers tightly

closed. Keep containers and surrounding areas well ventilated. Keep away from heat, flames and sparks. Protect this

product from light.

Incompatibilities:

strong oxidising agents, peroxides.

Fire Decomposition:

Carbon dioxide, and if combustion is incomplete, carbon monoxide and smoke. Hydrogen

chloride gas, other compounds of chlorine. Hydrogen fluoride gas and other compounds of fluorine. Water. Carbon

monoxide poisoning produces headache, weakness, nausea, dizziness, confusion, dimness of vision, disturbance of

judgment, and unconsciousness followed by coma and death.

Polymerisation:

This product will not undergo polymerisation reactions.

Section 11 - Toxicological Information

Local Effects:

Target Organs:

This product may attack central nervous system.

Classification of Hazardous Ingredients

Ingredient

Risk Phrases

No ingredient mentioned in the HSIS Database is present in this product at hazardous concentrations.

Section 12 - Ecological Information

Insufficient data to be sure of status. Expected to not be an environmental hazard as any material will rapidly

evaporate.

The stratospheric impact of Isoflurane and similar products and their influence on ozone depletion is of increasing

importance because of decreasing chlorofluorocarbons globally. However, the influence of volatile anaesthetics on

greenhouse warming is small.

Section 13 - Disposal Considerations

Disposal:

Dispose of small quantities and empty containers by wrapping with paper and putting with domestic

garbage. For larger quantities, if recycling or reclaiming is not possible, use a commercial waste disposal service.

Section 14 - Transport Information

ADG Code:

This product is not classified as a Dangerous Good when carried by road or rail in Australia. No special

transport conditions are necessary unless required by other regulations.

However, this is an Aviation Regulated Liquid, NOS. When carried by air

, the following apply:

ADG Code:

3334, Aviation Regulated Liquid, N.O.S.

Hazchem Code:

No Hazchem code specified.

Special Provisions:

106, 274, 276

Dangerous Goods Class:

9, Miscellaneous Dangerous Goods

Packaging Group:

No packing group specified.

Packaging Method:

No packaging methods specified.

Section 15 - Regulatory Information

AICS:

This product is compliant with NICNAS regulations.

Section 16 - Other Information

This MSDS contains only safety-related information. For other data see product literature.

Acronyms:

ADG Code

Australian Code for the Transport of Dangerous Goods by Road and Rail (7

edition)

Product Name: Delvet Isoflurane Inhalation Anaesthetic

Page: 5 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATA SHEET

Issued by: Delvet Pty Ltd

Phone: +61 2 9624 8844

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

AICS

Australian Inventory of Chemical Substances

ASCC

Office of the Australian Safety and Compensation Council

CAS number

Chemical Abstracts Service Registry Number

Hazchem Code

Emergency action code of numbers and letters that provide information to emergency

services especially firefighters

IARC

International Agency for Research on Cancer

NOS

Not otherwise specified

NTP

National Toxicology Program (USA)

R-Phrase

Risk Phrase

SUSDP

Standard for the Uniform Scheduling of Drugs & Poisons

UN Number

United Nations Number

THIS MSDS SUMMARISES OUR BEST KNOWLEDGE OF THE HEALTH AND SAFETY HAZARD INFORMATION OF THE PRODUCT AND

HOW TO SAFELY HANDLE AND USE THE PRODUCT IN THE WORKPLACE. EACH USER MUST REVIEW THIS MSDS IN THE CONTEXT OF

HOW THE PRODUCT WILL BE HANDLED AND USED IN THE WORKPLACE.

IF CLARIFICATION OR FURTHER INFORMATION IS NEEDED TO ENSURE THAT AN APPROPRIATE RISK ASSESSMENT CAN BE MADE,

THE USER SHOULD CONTACT THIS COMPANY SO WE CAN ATTEMPT TO OBTAIN ADDITIONAL INFORMATION FROM OUR SUPPLIERS

OUR RESPONSIBILITY FOR PRODUCTS SOLD IS SUBJECT TO OUR STANDARD TERMS AND CONDITIONS, A COPY OF WHICH IS SENT

TO OUR CUSTOMERS AND IS ALSO AVAILABLE ON REQUEST.

Please read all labels carefully before using product.

This MSDS is prepared in accord with the ASCC document “National Code of Practice for the Preparation

of Material Safety Data Sheets” 2nd Edition [NOHSC:2011(2003)]

Copyright © Kilford & Kilford Pty Ltd, October, 2008.

http://www.kilford.com.au/

Phone (02)9251 4532

Similar products

Search alerts related to this product

View documents history

Share this information